Paras Biopharmaceuticals Finland

Paras Biopharmaceuticals Finland is thrilled to be exhibiting again at #BIOEurope during March 17-19, 2025 in Milan! Schedule a meeting with us for discussions on our biologics CDMO scaleup & biosimilar technology development capabilities! Paras Biopharma has undertaken excellent projects for USA & European customers, including Biologics Scale-up, so also visit our Booth #12 for an informal chat and find out how we can help work best to your project requirements. Looking forward to seeing you in Milan! #biologics #CDMO #biosimilar #technologies #scaleup

For your complete biologics scale-up & downstream for IND enabling studies, choose Paras Biopharmaceuticals Finland as your first choice end-to-end partner! www.parasbiopharma.com #biologics #ind #downstream #scaleup #development #cdmo #biosimilars #technologies

Paras Biopharmaceuticals Finland has extensive Protein Purification capabilities and provides services for highly purified forms. Paras Biopharmaceuticals capabilties include equipment such as AxiChrom and ÄKTA Pilot with corresponding Bioprocess systems (3mm, 6mm, 10mm) for scale-up #production & #purification of #biologics. In addition, Paras Biopharma has the capabilities to reduce the room temperature of one of its purification suites down to 4C-8C, thus allowing the team to work on temperature-sensitive products. This has the additional benefit of extending the operational working period of a sensitive product. Paras Biopharmaceuticals' #microbial production facility in Finland has a total floor area of 25,000 ft2 and a classified cleanroom of 4,300 ft2. In addition to the above, the facility has a dedicated #GLP analytical laboratory, together with a number of corresponding analytical equipment, such as HPLCs, QTOF, GC-MS, etc. For more information, please visit https://zurl.co/SJqW

Paras Biopharmaceuticals Finland offers its services in two business segments: Paras Biologics https://zurl.co/v91w mainly focuses on #Biosimilars with the innovation of high-quality products, using its unique #technologies for this purpose. Our team has successfully developed high-value unique biosimilar candidates in its pipeline for “Rare & Orphan diseases” which are now available in the company’s portfolio and offered for co-development & partnership. In addition, Paras Biopharma (Biologics #CDMO) https://zurl.co/SDkq offers complete scale-up #biologics #production with batch capacities from 10/20 L up to 150 L & 750 L scale. Choose Paras as your reliable, esteemed partner for all your critical projects!

At Paras Biopharmaceuticals Finland we leave no stone unturned to meet the most rigorous quality standards. Our Biologics Development team takes immense pride to ensure delivery of the highest quality Biologic #Bulk to our esteemed clients in Europe & the USA. Contact us for more information about our end-to-end #biologics CDMO services and how we can assist with your project requirements! https://zurl.co/vLsk #production #quality #development

Are you working on your next Blockbuster Fc-Fusion? Paras Biopharmaceuticals Finland brings effective Fc-Fusion technology to its CDMO partners with: - Enhanced stability - Longer Half-Life - Reduced dosing frequency - More resistant to degradation - Improved bioavailability - More predictable and consistent pharmacological response - Reduced immunogenicity - Consistent efficacy Contact us to find out more. www.parasbiopharma.com

Expertise Meets Efficiency! At Paras Biopharmaceuticals Finland we specialize in custom #ancillary materials with a focus on speed & #precision. Our fast-track #biologics #manufacturing #capabilities ensure you get the #quality you need, when you need it. Partner with us today!

Ready to boost your #production capabilities during scale-up with tight deadlines? Paras Biopharmaceuticals Finland #technology suite - Biomultifold®, Diabrid®, NobelCleav®, and Cytofold StructQuant® ensures rapid and efficient development of your biologics projects. Our cutting-edge #solutions not only reduce timelines but also enhance productivity and #quality, delivering significant cost savings. Operating from our state-of-the-art facility in Finland, Paras' Biomultifold®, NobelCleav®, and Cytofold® StructQuant technologies synergize to achieve large-scale production swiftly and effectively. #biosimilar #technologies #fcfusion #cdmo #manufacturing

For your complete biologics scale-up & downstream for IND enabling studies, choose Paras Biopharmaceuticals Finland as your first choice end-to-end partner! #biologics #ind #downstream #scaleup #development #cdmo #biosimilars #technologies

Paras Biopharmaceuticals Finland is ready for the Pre-JPM Digital Partnering event, taking place next week from December 2-6th! Schedule a meeting with us for discussions about our Biologics, Biosimilar / Biobetter & Advanced Technology capabilities! #production #cdmo #scaleup #oncology #itp #oncoimmunology